Skip to content
Albuterol
Accuneb, Airsupra, Combivent, Proair, Proventil, Proventil-hfa, Ventolin (albuterol) is a small molecule pharmaceutical. Albuterol was first approved as Ventolin on 1982-01-01. It is used to treat asthma and bronchial spasm in the USA. The pharmaceutical is active against beta-2 adrenergic receptor.
Download report
Favorite
Top Prescription Drugs
Top 200 Pharmaceuticals by Retail Sales
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
immune system diseasesD007154
Trade Name
FDA
EMA
Accuneb, Proair, Proventil-hfa, Ventolin (generic drugs available since 1989-12-05, discontinued: Proventil, Ventolin, Ventolin rotacaps, Volmax, Vospire)
Combinations
Airsupra, Combivent (generic drugs available since 1989-12-05, discontinued: Duoneb)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Albuterol
Tradename
Company
Number
Date
Products
VENTOLINGSKN-018473 DISCN1982-01-01
1 products
PROVENTILMerck Sharp & DohmeN-017559 DISCN1982-01-01
1 products
Hide discontinued
Albuterol sulfate
Tradename
Company
Number
Date
Products
VENTOLIN HFAGSKN-020983 RX2001-04-19
1 products, RLD, RS
PROVENTIL-HFAKindeva Drug DeliveryN-020503 RX1996-08-15
1 products, RLD, RS
ACCUNEBMylanN-020949 RX2001-04-30
1 products, RLD, RS
PROAIR HFATevaN-021457 RX2004-10-29
1 products, RLD, RS
PROAIR DIGIHALERTevaN-205636 RX2018-12-21
1 products, RLD
PROAIR RESPICLICKTevaN-205636 RX2015-03-31
1 products, RLD, RS
Show 11 discontinued
Albuterol sulfate
+
Budesonide
Tradename
Company
Number
Date
Products
AIRSUPRAAstraZenecaN-214070 RX2023-01-10
1 products, RLD, RS
Albuterol sulfate
+
Ipratropium bromide
Tradename
Company
Number
Date
Products
COMBIVENT RESPIMATBoehringer IngelheimN-021747 RX2011-10-07
1 products, RLD, RS
Show 2 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
combivent respimatNew Drug Application2022-01-24
proair respiclickNew Drug Application2023-06-07
proventil hfaNew Drug Application2021-06-03
truemed group llcExport only2022-08-11
ventolinNew Drug Application2021-08-18
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
asthmaEFO_0000270D001249J45
bronchial spasm—D001986—
Agency Specific
FDA
EMA
Expiration
Code
ALBUTEROL SULFATE / BUDESONIDE, AIRSUPRA, ASTRAZENECA
2026-01-10NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Albuterol Sulfate, Proair Digihaler, Teva Branded Pharm
112667962041-02-22DP
111732592040-07-06DP
114649232040-06-19DP
114397772040-05-24DP
113446852039-09-26DP
110006532038-12-18DP
113579352038-09-24DP
113513172038-02-10DP
105690342036-08-16DP
109188162035-12-14DP
97825502035-08-28DP
97825512035-08-28DP
89789662032-01-13DP
105618082032-01-01DP
92162602031-06-28DP
97310872031-05-18DP
100225102031-05-18DP
101241312031-05-18DP
86511032028-03-26DP
94632882025-05-19DP
107658202025-05-19DP
75402822023-05-06DP
Albuterol Sulfate, Proair Hfa, Teva Branded Pharm
94632892031-05-18DP
98085872031-05-18DP
100225092031-05-18DP
100861562031-05-18DP
106955122031-05-18DP
113958892031-05-18DP
81327122028-09-07DP
71051522023-09-12DP
Albuterol Sulfate / Ipratropium Bromide, Combivent Respimat, Boehringer Ingelheim
87333412030-10-16DP
78372352028-03-13DP
90279672027-03-31DP
73963412026-10-10DP
78962642025-05-26DP
72844742024-08-26DP
Albuterol Sulfate / Budesonide, Airsupra, Astrazeneca
94150092030-05-28U-3509
Albuterol Sulfate, Ventolin Hfa, Glaxosmithkline
75004442026-02-26DP
78323512023-06-19DP
ATC Codes
R: Respiratory system drugs
— R03: Drugs for obstructive airway diseases
— R03A: Adrenergics, inhalants
— R03AC: Selective beta-2-adrenoreceptor agonist inhalants
— R03AC02: Salbutamol
— R03AK: Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics
— R03AK04: Salbutamol and sodium cromoglicate
— R03AK13: Salbutamol and beclometasone
— R03AL: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
— R03AL02: Salbutamol and ipratropium bromide
— R03C: Adrenergics for systemic use
— R03CC: Selective beta-2-adrenoreceptor agonists, systemic
— R03CC02: Salbutamol
HCPCS
Code
Description
J7607
Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
J7609
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
J7610
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
J7611
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
J7613
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
J7614
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
J7615
Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
J7620
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
Clinical
Clinical Trials
387 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AsthmaD001249EFO_0000270J451236624828186
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.94824262082
Healthy volunteers/patients—91—1516
Exercise-induced asthmaD001250J45.990——32—5
Status asthmaticusD01322421—2—5
Disease progressionD018450———213
Obstructive lung diseasesD008173HP_0006536—1—113
HyperkalemiaD006947HP_0002153E87.5———213
Pediatric obesityD063766———213
Airway obstructionD000402———123
Show 19 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lung diseasesD008171EFO_0003818J98.41—1—24
HypersensitivityD006967EFO_0003785T78.40—13——3
Heart failureD006333EFO_0003144I50—12—13
Bronchial spasmD001986—21——3
ConjunctivitisD003231H10——2——2
RhinitisD012220EFO_0008521J31——2——2
Myasthenia gravisD009157EFO_0004991G70.0—11——1
Pulmonary arterial hypertensionD000081029——1——1
Familial dysautonomiaD004402Orphanet_1764G90.1——1——1
Organophosphate poisoningD062025——1——1
Show 1 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
BronchiolitisD001988HP_001195011——13
CoughD003371HP_0012735R05—1——23
Pulmonary hypertensionD006976EFO_0001361I27.20—1———1
Familial primary pulmonary hypertensionD065627I27.0—1———1
LymphangioleiomyomatosisD018192J84.8111———1
Viral bronchiolitisD001990—1———1
Brain deathD001926G93.82—1———1
Pulmonary edemaD011654EFO_1001134J81—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E132————2
Drug-related side effects and adverse reactionsD064420T88.71————1
Major depressive disorderD003865EFO_0003761F221————1
Sickle cell anemiaD000755EFO_0000697D571————1
Idiopathic pulmonary fibrosisD054990J84.1121————1
Congenital myasthenic syndromesD020294Orphanet_590G70.21————1
Ciliary motility disordersD002925EFO_00039001————1
Transient tachypnea of the newbornD059245P22.11————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cystic fibrosisD003550EFO_0000390E84————44
SmokingD012907EFO_0003768F17————33
Airway remodelingD056151————22
PneumoniaD011014EFO_0003106J18————11
Obstructive sleep apneaD020181EFO_0003918G47.33————11
VirusesD014780NCBITaxon_10239STY/T005————11
Food hypersensitivityD005512EFO_1001890————11
Insulin resistanceD007333EFO_0002614————11
Alpha 1-antitrypsin deficiencyD019896E88.01————11
Argininosuccinic aciduriaD056807————11
Show 30 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameALBUTEROL
INNsalbutamol
Description
Albuterol is a member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It has a role as a bronchodilator agent, a beta-adrenergic agonist, an environmental contaminant and a xenobiotic. It is a member of phenylethanolamines, a secondary amino compound and a member of phenols.
Classification
Small molecule
Drug classbronchodilators (phenethylamine derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1
Identifiers
PDB—
CAS-ID18559-94-9
RxCUI—
ChEMBL IDCHEMBL714
ChEBI ID2549
PubChem CID2083
DrugBankDB01001
UNII IDQF8SVZ843E (ChemIDplus, GSRS)
Target
Agency Approved
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
154
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Q9UMZ5
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Alternate
No data
Variants
Clinical Variant
No data
Financial
Proair - Teva
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 24,541 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
29,649 adverse events reported
View more details